|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 02/21/23
- Walmart sees operating income flat in Q2 vs. last year
- 02/21/23
- Walmart sees sales growth strongest in 1H, moderating in 2H
- 02/21/23
- Walmart sees gross margin levels up in FY24, but not back to FY22 levels
- 02/21/23
- Walmart sees 'great deal of uncertainty' this year
- 02/16/23
- Vir Biotechnology appoints Sung Lee as Chief Financial Officer
- 02/13/23
- Vir Biotechnology announces amended collaboration pact with GSK
- 01/25/23
- Vir Biotechnology announces retirement of CEO, Backer to succeed
- 12/21/22
- Vir Biotechnology achieves target enrollment for Phase 2 PENINSULA trial
TVTX Travere Therapeutics - 02/17/23
- Ligand's partner Travere Therapeutics gets FDA accelerated approval of Filspari
- 02/17/23
- Travere Therapeutics trading resumes
- 02/17/23
- Travere Therapeutics announces FDA accelerated approval of Filspari
- 02/17/23
- Travere Therapeutics trading halted, volatility trading pause
- 02/14/23
- Lone Pine exited PayPal, initiated AMD position during Q4
- 01/24/23
- Taiwan Semi trading resumes
- 01/24/23
- Taiwan Semi trading halted, volatility trading pause
- $197.35 /
-10.96 (-5.26%) - 02/21/23
- EU passenger car registrations up 11.3% in January
- 02/17/23
- Sigma Lithium jumps 27% to $37.49 after Bloomberg reports Tesla mulls offer
- 02/16/23
- Musk says 'flat wrong' to call Tesla over-the-air software update a 'recall'
- 02/16/23
- Tesla recalls 362,758 Full Self-Driving vehicles, issuing software update
- 02/21/23
- Teck Resources sees 2023 copper production 390K-445K tons
- 02/21/23
- Teck Resources introduces six-year sunset for dual class share structure
- 02/21/23
- Teck Resources announces agreement with Nippon Steel, POSCO
- 02/21/23
- Teck Resources to separate into two publicly-listed companies
- 02/15/23
- Frontier Communications, AT&T enter wireless infrastructure deal
- 02/08/23
- 3M appoints Anne Chow and Pedro Pizarro to Board of Directors
- 01/25/23
- AT&T says outlook 'conservative' given economic uncertainty
- 01/25/23
- AT&T says ARPU growth continuing to come in ahead of expectations
- 02/17/23
- RE/MAX Holdings falls -16.2%
- 02/17/23
- RE/MAX Holdings falls -11.7%
- 01/19/23
- Redfin: Median U.S. home-sale price increased 0.9% for four weeks ending Jan. 15
- 01/05/23
- Redfin: Pending U.S. home sales dropped 32% y/y during four weeks ending Jan1
- 02/21/23
- Nvidia CEO Jensen Huang to deliver keynote at GTC 2023
- 02/14/23
- One Stop Systems receives $1.3M order from U.S. Army to develop vehicle systems
- 02/21/23
- EPA requires Norfolk Southern to conduct all cleanup actions in Ohio
- 02/21/23
- EPA orders to Norfolk to clean up, reimburse costs for Ohio derailment
- 02/16/23
- Norfolk Southern CEO says crews are cleaning site in East Palestine, Ohio
- 02/15/23
- Norfolk Southern expanding area eligible for reimbursements in Ohio
- 02/21/23
- Microsoft says Nvidia offering 'full support' for Activision deal
- 02/21/23
- Microsoft, Nvidia announce 'expansive' new gaming partnership
- 02/21/23
- Microsoft signs 10-year contract to bring Xbox games to Nintendo platforms
- 02/17/23
- Microsoft says new Bing a work in progress
- 02/20/23
- Fly Intel: Top five weekend stock stories
- 02/19/23
- Meta testing subscription service for $11.99 a month
- 02/16/23
- TikTok debuts 'TikTok Trivia,' a live 5-day trivia game with prize pool
- 02/16/23
- Instagram debuts Broadcast Channels, helping creators to deepen connections
- 02/21/23
- Medtronic sees Q4 organic revenue up 4.5%-5%
- 02/17/23
- Medtronic receives CE Mark for extravascular defibrillator system
- 02/08/23
- Medtronic announces late-breaking clinical data from STROKE AF trial
- 01/30/23
- Medtronic recalls Hemodialysis Catheters for leaks, FDA says
- 02/21/23
- Helix Energy rises 15.5%
- 02/21/23
- Helix Energy rises 11.4%
- 02/20/23
- Helix Energy announces $200M share repurchase program
- 11/22/22
- Helix Energy announces contract extension with Talos for Helix Producer I
- $295.54 /
-22.55 (-7.09%) - 02/21/23
- Home Depot says seeing very good project demand
- 02/21/23
- Home Depot expects flat consumer spending in 2023
- 02/21/23
- Home Depot says big ticket comps up 3.8% y/y in Q4
- 02/21/23
- Home Depot says seeing traction in interconnected business
- 11/17/22
- Expeditors exec Alger sells 11,500 common shares
- 02/16/23
- DocuSign announces restructuring plan, to reduce workforce by 10%
- 01/30/23
- DocuSign expands leadership team with two newly created roles
- 12/08/22
- DocuSign jumps 14% to $49.80 after Q3 results beat estimates
- 12/08/22
- DocuSign reports Q3 adjusted gross margin 83% vs. 82% last year
- $102.06 /
-3.165 (-3.01%) - 02/21/23
- Disney reports 'Ant-Man and The Wasp: Quantumania' opening totals $249.7M
- 02/21/23
- Disney says 'Avatar: The Way of Water' now third highest-grossing film ever
- 02/21/23
- Imax reports $24M four-day global box office for Disney's "Ant-Man" film
- $15.53 /
-3.315 (-17.60%) - 02/21/23
- Dana falls -13.8%
- 02/21/23
- Dana falls -11.2%
- 02/21/23
- Dana falls -11.7%
- 02/21/23
- Dana selected by Wacker Neuson Group to provide e-propulsion system
- 02/16/23
- Stifel Financial announces launch of an ASPG, new hires
- 02/09/23
- Credit Suisse announces acquisition of The Klein Group LLC for $175M
- 02/09/23
- Credit Suisse warns of 'substantial loss before taxes' for 2023
- 02/09/23
- Credit Suisse expects to report a loss for WM, IB in Q1
- 02/21/23
- BioCryst sees 2023 ORLADEYO revenue no less than $320M
- 02/06/23
- BioCryst reports inducement grants under Nasdaq listing rule
- 01/26/23
- BioCryst begins enrollment in APeX-P trial evaluating ORLADEYO
- 01/23/23
- BioCryst selects Swixx BioPharma as commercial partner for ORLADEYO
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
ATNM Actinium Pharmaceuticals - $11.37 /
-2.315 (-16.92%) - 02/21/23
- Actinium Pharmaceuticals announces 'positive' phase 3 SIERRA trial data in AML
- 02/06/23
- Actinium Pharmaceuticals signs R&D agreement with National Cancer Institute
- 12/12/22
- Actinium highlights overall survival rates in its Actimab-A CLAG-M trial
- 12/08/22
- Actinium, Columbia University to study Actimab-A in AML patients
- 02/17/23
- Apellis Pharmaceuticals trading resumes
- 02/17/23
- Apellis says FDA approves SYFOVRE for GA treatment
- 02/17/23
- Iveric bio rallies 23% to $24.70 after FDA approves Apellis drug
- 02/17/23
- Apellis' Syfovre new drug application approved by FDA
- $143.32 /
-14.06 (-8.93%) - 12/30/22
- AutoNation former director and investor Ed Lampert sells $1.3M in common stock
- 12/12/22
- AutoNation to expand after-sales business with acquisition of RepairSmith
- 11/15/22
- AutoNation acquires 6.1% ownership stake in TrueCar
- 10/27/22
- AutoNation to acquire four dealerships with $320M in annual revenue
- 11/08/22
- Adtran sees continued supply chain challenges ahead
- $295.54 /
-22.55 (-7.09%) - 02/22/23 Barclays
- Home Depot price target lowered to $310 from $323 at Barclays
- 02/21/23 Baird
- Home Depot price target lowered to $340 from $360 at Baird
- 02/17/23 Evercore ISI
- Home Depot added to 'Tactical Underperform' list at Evercore ISI
- 02/15/23 Piper Sandler
- Home Depot price target lowered to $300 from $320 at Piper Sandler
- 02/21/23 BofA
- BofA sees 12M potential subscriber opportunity for Meta Verified
- 02/13/23 BofA
- BofA sees room for additional efficiencies at Meta
- 02/10/23 Tigress Financial
- Meta Platforms price target raised to $285 from $260 at Tigress Financial
- 02/08/23 Loop Capital
- Meta Platforms price target raised to $188 from $165 at Loop Capital
- 02/16/23 Canaccord
- Teck Resources upgraded to Buy at Canaccord on coal spin potential
- 02/16/23 Canaccord
- Teck Resources upgraded to Buy from Hold at Canaccord
- 02/13/23 National Bank
- Teck Resources price target raised to C$70 from C$65 at National Bank
- 02/01/23 RBC Capital
- Teck Resources price target raised to C$64 from C$62 at RBC Capital
- $102.06 /
-3.165 (-3.01%) - 02/13/23 JPMorgan
- Disney reinstated with an Overweight at JPMorgan
- 02/13/23 Citi
- Disney price target lowered to $130 from $145 at Citi
- 02/09/23 Loop Capital
- Disney price target raised to $130 from $120 at Loop Capital
- 02/09/23 BofA
- Disney price target raised to $135 from $115 at BofA
- 02/16/23 Deutsche Bank
- Deutsche upgrades Activision to Buy, says best risk/reward in gaming
- 02/13/23 Morgan Stanley
- Morgan Stanley sees 5 quarters of accelerating EPS growth at Microsoft after Q2
- 02/13/23 BofA
- BofA starts Okta at Underperform with 'no positive catalysts in sight'
- 02/10/23 Roth MKM
- Activision Blizzard price target lowered to $88 from $95 at Roth MKM
- 02/21/23 BMO Capital
- Nvidia price target raised to $240 from $210 at BMO Capital
- 02/21/23 Stifel
- Nvidia price target raised to $207 from $175 at Stifel
- 02/21/23 Morgan Stanley
- Nvidia price target raised to $246 from $175 at Morgan Stanley
- 02/17/23 Oppenheimer
- Nvidia price target raised to $250 from $225 at Oppenheimer
- 02/16/23 Deutsche Bank
- Activision Blizzard upgraded to Buy from Hold at Deutsche Bank
- 02/08/23 Morgan Stanley
- Activision Blizzard risk/reward 'highly compelling,' says Morgan Stanley
- 02/21/23 Goldman Sachs
- Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
- 01/27/23 Morgan Stanley
- Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
- 09/14/22 SVB Securities
- SVB Securities bullish on Vir Biotechnology, initiates with an Outperform
- 09/14/22 SVB Securities
- Vir Biotechnology initiated with an Outperform at SVB Securities
- 02/21/23 Wolfe Research
- Norfolk Southern upgraded to Outperform from Peer Perform at Wolfe Research
- 02/14/23 BofA
- Norfolk Southern derailment EPS impact likely minimal given insurance, says BofA
- 01/26/23 BMO Capital
- Norfolk Southern price target raised to $250 from $245 at BMO Capital
- 01/26/23 RBC Capital
- Norfolk Southern price target lowered to $244 from $253 at RBC Capital
- $143.32 /
-14.06 (-8.93%) - 02/21/23 Guggenheim
- AutoNation price target raised to $181 from $169 at Guggenheim
- 02/21/23 Wells Fargo
- AutoNation price target raised to $154 from $126 at Wells Fargo
- 02/21/23 JPMorgan
- AutoNation downgraded to Underweight from Neutral at JPMorgan
- 01/17/23 Morgan Stanley
- AutoNation downgraded to Underweight from Equal Weight at Morgan Stanley
- 02/21/23 UBS
- DocuSign downgraded to Sell from Neutral at UBS
- 02/16/23 MoffettNathanson
- DocuSign price target lowered to $50 from $63 at MoffettNathanson
- 01/05/23 Jefferies
- DocuSign upgraded to Buy from Hold at Jefferies
- 01/05/23 Piper Sandler
- DocuSign price target raised to $55 from $50 at Piper Sandler
- 02/21/23 Stephens
- RE/MAX Holdings downgraded to Equal Weight at Stephens on lack of catalysts
- 02/21/23 Stephens
- RE/MAX Holdings downgraded to Equal Weight from Overweight at Stephens
- 03/02/22 JonesResearch
- RE/MAX Holdings initiated with a Buy at JonesTrading
- 02/28/22 Keefe Bruyette
- RE/MAX Holdings price target lowered to $35 from $37 at Keefe Bruyette
- 02/16/23 Citi
- Credit Suisse downgraded at Citi on franchise erosion and poor visibility
- 02/16/23 Citi
- Credit Suisse downgraded to Neutral from Buy at Citi
- 02/13/23 Kepler Cheuvreux
- Kepler downgrades Credit Suisse to Reduce on earnings concerns
- 02/13/23 Kepler Cheuvreux
- Credit Suisse downgraded to Reduce from Hold at Kepler Cheuvreux
- 01/27/23 BofA
- Intel price target lowered to $25 from $28 at BofA
- 01/12/23 Needham
- Impinj price target raised to $130 from $120 at Needham
- 01/10/23 Morgan Stanley
- TSMC named a 'Catalyst Driven Idea' at Morgan Stanley
- 11/18/22 Erste Group
- TSMC upgraded to Buy from Hold at Erste Group
- $197.35 /
-10.96 (-5.26%) - 02/22/23 Bernstein
- Pricing among important issues into Tesla's analyst day, says Bernstein
- 02/21/23 Wells Fargo
- Wells Fargo says Tesla possible lithium play would secure capacity
- 02/20/23 Wells Fargo
- Tesla risks 'clearly remain' after self driving recall, says Wells Fargo
- 02/16/23 Gordon Haskett
- Natixis doesn't hold 190M share Tesla stake, admits error, says Gordon Haskett
- 02/15/23 Wells Fargo
- Wells Fargo downgrades Dycom to Equal Weight, lowers price target to $88
- 02/07/23 LightShed Partners
- AT&T downgraded to Neutral from Buy at LightShed Partners
- 02/06/23 MoffettNathanson
- T-Mobile downgraded at MoffettNathanson amid 'great deceleration'
- 01/26/23 TD Cowen
- AT&T price target raised to $25 from $24 at Cowen
TVTX Travere Therapeutics - 02/21/23 Canaccord
- Travere Therapeutics price target raised to $44 from $40 at Canaccord
- 02/21/23 Evercore ISI
- Travere Therapeutics price target raised to $36 from $30 at Evercore ISI
- 02/21/23 Piper Sandler
- Travere Therapeutics price target raised to $46 from $42 at Piper Sandler
- 02/21/23 Wedbush
- Wedbush upgrades Travere Therapeutics to Outperform, raises target to $30
- 01/03/23 BTIG
- Helix Energy named Top Pick for first half of 2023 at BTIG
- 10/26/22 BTIG
- Helix Energy upgraded to Buy from Neutral at BTIG
- 10/07/22 Piper Sandler
- Helix Energy assumed with an Overweight at Piper Sandler
- 07/27/22 Evercore ISI
- Helix Energy upgraded to Outperform at Evercore ISI as second half ramp begins
- 02/21/23 H.C. Wainwright
- H.C. Wainwright says Belite Bio opportunity intact despite GA treatment approval
- 02/21/23 BofA
- Apellis price target raised to $115 from $79 at BofA
- 02/21/23 Stifel
- Apellis price target raised to $75 from $65 at Stifel
- 02/21/23 Baird
- Apellis price target raised to $105 from $90 at Baird
ATNM Actinium Pharmaceuticals - $11.37 /
-2.315 (-16.92%) - 02/21/23 William Blair
- Actinium downgraded despite positive data at William Blair
- 02/21/23 William Blair
- Actinium Pharmaceuticals downgraded to Market Perform from Outperform at William Blair
- 10/31/22 Maxim
- Actinium Pharmaceuticals price target raised to $35 from $25 at Maxim
- 10/31/22 B. Riley
- Actinium Pharmaceuticals price target raised to $18 from $16 at B. Riley
- 01/09/23 Piper Sandler
- BioCryst reports preliminary Q4 miss for Orladeyo, says Piper Sandler
- 12/16/22 Barclays
- BioCryst price target lowered to $10 from $12 at Barclays
- 12/15/22 Oppenheimer
- Oppenheimer keeps Perform on BioCryst after discontinuation of BCX9930 program
- 12/15/22 TD Cowen
- Cowen says full sale of BioCryst 'potentially now even more likely'
- $15.53 /
-3.315 (-17.60%) - 02/22/23 Barclays
- Dana price target lowered to $18 from $20 at Barclays
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 02/14/23 Barclays
- Dana initiated with an Equal Weight at Barclays
- 01/19/23 Deutsche Bank
- Deutsche Bank keeps Hold on Dana, raises price target to $16
- 02/17/23 Evercore ISI
- Walmart added to 'Tactical Outperform' list at Evercore ISI
- 02/15/23 TD Cowen
- Walmart price target raised to $180 from $175 at Cowen
- 02/14/23 Roth MKM
- Walmart to get more aggressive on food pricing and market share, says Roth MKM
- 02/10/23 Gordon Haskett
- Gordon Haskett upgrades Walmart to Accumulate on price leadership
- 09/26/22 Loop Capital
- Adtran upgraded to Buy from Hold at Loop Capital
- 09/26/22 Loop Capital
- Adtran upgraded to Buy from Hold at Loop Capital
- 09/13/22 WestPark Capital
- Adtran initiated with a Hold at WestPark Capital
- 07/14/22 Needham
- Adtran initiated with a Buy at Needham
- 01/06/23 TD Cowen
- Expeditors price target lowered to $108 from $122 at Cowen
- 11/22/22 Wells Fargo
- Wells Fargo downgrades Expeditors to Underweight with $95 price target
- 11/22/22 Wells Fargo
- Expeditors downgraded to Underweight from Equal Weight at Wells Fargo
- 11/09/22 Susquehanna
- Expeditors price target lowered to $95 from $110 at Susquehanna
- 12/22/22 EF Hutton
- KLX Energy assumed with a Buy at EF Hutton
- 11/21/22 EF Hutton
- KLX Energy initiated with a Buy at EF Hutton
- 11/18/22 Piper Sandler
- KLX Energy price target raised to $19 from $10 at Piper Sandler
- 10/07/22 Piper Sandler
- KLX Energy assumed with a Neutral at Piper Sandler
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/24/23 Mizuho
- Medtronic price target lowered to $95 from $100 at Mizuho
- 01/09/23 RBC Capital
- Medtronic downgraded to Sector Perform from Outperform at RBC Capital
- 11/30/22 Wells Fargo
- Medtronic price target lowered to $77 from $82 at Wells Fargo
- 02/21/23
- Walmart sees FY24 adjusted EPS $5.90-$6.05, consensus $6.50
- 02/21/23
- Walmart sees Q1 adjusted EPS $1.25-$1.30, consensus $1.36
- 02/21/23
- Walmart reports Q4 adjusted EPS $1.71, consensus $1.51
- 11/15/22
- Walmart raises FY23 adjusted EPS view to down 5%-6% from down 9%-11%
- 11/03/22
- Vir Biotechnology reports Q3 EPS $1.30, consensus (21c)
TVTX Travere Therapeutics - 01/09/23
- Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15
- 10/27/22
- Travere Therapeutics reports Q3 EPS (76c), consensus (86c)
- 01/12/23
- TSMC sees Q1 revenue $16.7B-$17.5B, consensus $17.71B
- 01/12/23
- TSMC reports Q4 EPS $1.82, consensus $1.77
- 10/13/22
- TSMC sees Q4 revenue $19.9B-$20.7B, consensus $19.76B
- 10/13/22
- TSMC reports Q3 EPS $1.79, consensus $1.41
- $197.35 /
-10.96 (-5.26%) - 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 02/21/23
- Teck Resources reports Q4 adjusted EPS C$1.07 vs. C$2.54 a year ago
- 10/27/22
- Teck Resources reports Q3 adjusted EPS C$1.74 vs. C$1.88 last year
- 01/25/23
- AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56
- 01/25/23
- AT&T reports Q4 adjusted EPS 61c, consensus 57c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 02/16/23
- RE/MAX Holdings sees FY23 revenue $315M-$335M, consensus $354.28M
- 02/16/23
- RE/MAX Holdings sees Q1 revenue $82M-$87M, consensus $86.88M
- 02/16/23
- RE/MAX Holdings reports Q4 adjusted EPS 41c, consensus 42c
- 11/03/22
- RE/MAX Holdings sees FY22 revenue $352M-$357M, consensus $358.92M
- 11/16/22
- Nvidia sees Q4 revenue $6B, +/- 2%, consensus $6.09B
- 11/16/22
- Nvidia reports Q3 EPS 58c, consensus 69c
- 11/16/22
- Notable companies reporting after market close
- 08/24/22
- Nvidia down 5% after Q2 report, Q3 guidance
- 01/25/23
- Norfolk Southern reports Q4 EPS $3.42, consensus $3.44
- 10/26/22
- Norfolk Southern reports Q3 EPS $4.10, consensus $3.64
- 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 02/21/23
- Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58
- 02/21/23
- Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30
- 02/21/23
- Medtronic reports Q3 EPS $1.30, consensus $1.27
- 11/22/22
- Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40
- 02/21/23
- KLX Energy sees Q4 revenue $221.5M-$223.5M, consensus $222.07M
- 02/21/23
- Helix Energy sees FY23 revenue $1.02B-$1.2B, consensus $1.08B
- 02/20/23
- Helix Energy reports Q4 EPS 2c, consensus 0c
- 10/25/22
- Helix Energy sees FY22 revenue $785M-$860M, consensus $769.93M
- 10/24/22
- Helix Energy reports Q3 EPS (12c), consensus (1c)
- $295.54 /
-22.55 (-7.09%) - 02/21/23
- Home Depot sees FY23 EPS down mid-single digits percent range, consensus $16.65
- 02/21/23
- Home Depot reports Q4 EPS $3.30, consensus $3.28
- 11/15/22
- Home Depot backs FY22 EPS view up mid-single digits, consensus $16.58
- 11/15/22
- Home Depot reports Q3 EPS $4.24, consensus $4.13
- 02/21/23
- Expeditors reports Q4 EPS $1.38, consensus $1.96
- 11/08/22
- Expeditors reports Q3 EPS $2.54, consensus $1.95
- 12/08/22
- DocuSign sees FY23 revenue $2.493B-$2.497B, consensus $2.49B
- 12/08/22
- DocuSign sees Q4 revenue $637M-$641M, consensus $640.51M
- 12/08/22
- DocuSign reports Q3 adjusted EPS 57c, consensus 42c
- 12/08/22
- Notable companies reporting after market close
- $102.06 /
-3.165 (-3.01%) - 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- $15.53 /
-3.315 (-17.60%) - 02/21/23
- Dana sees FY23 adjusted EPS 25c-75c, consensus $1.73
- 02/21/23
- Dana reports Q4 EPS (10c), consensus 26c
- 10/27/22
- Dana backs FY22 adjusted EPS view 60c-90c, consensus 68c
- 10/27/22
- Dana reports Q3 adjusted EPS 24c, consensus 22c
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 02/21/23
- BioCryst reports Q4 adjusted EPS (38c), consensus (17c)
- 11/01/22
- BioCryst sees FY22 ORLADEYO revenue $255M
- 11/01/22
- BioCryst reports Q3 EPS (23c), consensus (29c)
- 02/06/23
- Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51
- 02/06/23
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- $143.32 /
-14.06 (-8.93%) - 02/17/23
- AutoNation reports Q4 adjusted EPS $6.37, consensus $5.83
- 02/16/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- AutoNation reports Q3 adjusted EPS $6.00, consensus $6.27
- 02/21/23
- Adtran sees Q1 revenue $355M-$375M, consensus $365.07M
- 02/21/23
- Adtran reports preliminary Q4 EPS 12c, consensus 16c
- 11/08/22
- Adtran sees Q4 revenue $355M-$375M, consensus $363.2M
- 11/08/22
- Adtran reports Q3 EPS 11c, consensus 18c
|
